ACE and diabetes mellitus: Notably, a lower likelihood of deintensification was found among patients receiving angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers as well as statins, which suggests that patients with diabetes complications that were being managed more aggressively were less likely to experience treatment deintensification.